341 related articles for article (PubMed ID: 18173535)
21. Diphencyprone in the management of refractory palmoplantar and periungual warts: an open study.
Rampen FH; Steijlen PM
Dermatology; 1996; 193(3):236-8. PubMed ID: 8944347
[TBL] [Abstract][Full Text] [Related]
22. [Skin irritation caused by frequently applied dermatologic agents].
Pambor M; Wagner E
Z Arztl Fortbild (Jena); 1966 Jul; 60(14):847-51. PubMed ID: 4230890
[No Abstract] [Full Text] [Related]
23. Narrow-band ultraviolet B treatment for diphenylcyclopropenone-induced vitiliginous lesions.
Oh YJ; Shin MK; Lee MH
Acta Derm Venereol; 2012 Jan; 92(1):102-3. PubMed ID: 22215015
[No Abstract] [Full Text] [Related]
24. Treatment of multiple relapsing warts with diphenciprone.
Orecchia G; Douville H; Santagostino L; Rabbiosi G
Dermatologica; 1988; 177(4):225-31. PubMed ID: 3224730
[TBL] [Abstract][Full Text] [Related]
25. Bacille Calmette-Guerin immunotherapy of viral warts.
Sharquie KE; Al-Rawi JR; Al-Nuaimy AA; Radhy SH
Saudi Med J; 2008 Apr; 29(4):589-93. PubMed ID: 18382805
[TBL] [Abstract][Full Text] [Related]
26. Recalcitrant viral warts treated by diphencyprone immunotherapy.
Buckley DA; Keane FM; Munn SE; Fuller LC; Higgins EM; Du Vivier AW
Br J Dermatol; 1999 Aug; 141(2):292-6. PubMed ID: 10468802
[TBL] [Abstract][Full Text] [Related]
27. Treatment of alopecia areata with diphencyprone.
Hatzis J; Georgiotouo K; Kostakis P; Anastasiadis G; Tosca A; Varelzidis A; Straigos J
Australas J Dermatol; 1988 Apr; 29(1):33-6. PubMed ID: 2977943
[No Abstract] [Full Text] [Related]
28. Vitiligo following diphencyprone dermatitis.
MacDonald-Hull SP; Cotterill JA; Norris JF
Br J Dermatol; 1989 Feb; 120(2):323. PubMed ID: 2522312
[No Abstract] [Full Text] [Related]
29. Successful treatment of disseminated facial verrucae with contact immunotherapy.
Weisshaar E; Neumann HJ; Gollnick H
Eur J Dermatol; 1998; 8(7):488-91. PubMed ID: 9854160
[TBL] [Abstract][Full Text] [Related]
30. Facial eruption of viral warts in a child treated with 0.03% tacrolimus ointment for atopic dermatitis.
Patrizi A; Neri I; Bianchi F; Passarini B; Ricci G
Pediatr Dermatol; 2007; 24(4):445-7. PubMed ID: 17845188
[No Abstract] [Full Text] [Related]
31. Treatment of warts with contact allergens.
Word AP; Nezafati KA; Cruz PD
Dermatitis; 2015; 26(1):32-7. PubMed ID: 25581668
[TBL] [Abstract][Full Text] [Related]
32. Dermatitis from applied medicaments.
Bandmann HJ; Calnan CD; Cronin E; Fregert S; Hjorth N; Magnusson B; Maibach H; Malten KE; Meneghini CL; Pirilä V; Wilkinson DS
Arch Dermatol; 1972 Sep; 106(3):335-7. PubMed ID: 4262389
[No Abstract] [Full Text] [Related]
33. Allergic contact dermatitis from dyes in wigs following diphencyprone treatment.
Crichlow S; Warin AP
Contact Dermatitis; 2004 Sep; 51(3):148-9. PubMed ID: 15479204
[No Abstract] [Full Text] [Related]
34. [Intolerance reactions to non-steroidal antiphlogistics and analgesics in chronic recurrent urticaria].
Ziegler B; Haustein UF
Dermatol Monatsschr; 1986; 172(6):313-7. PubMed ID: 2943611
[No Abstract] [Full Text] [Related]
35. Dermatitis produced by applications of monobenzone in patients with active vitiligo.
Nordlund JJ; Forget B; Kirkwood J; Lerner AB
Arch Dermatol; 1985 Sep; 121(9):1141-4. PubMed ID: 2931053
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of diphencyprone immunotherapy for the treatment of cutaneous warts: a systematic review and meta-analysis.
Leeyaphan C; Tantrapornpong P; Ungprasert P
J Dermatolog Treat; 2021 Sep; 32(6):658-662. PubMed ID: 31679413
[TBL] [Abstract][Full Text] [Related]
37. Unique Case of Urticarial Skin Eruptions After COVID-19 Vaccination.
Baraldi C; Boling LB; Patrizi A; Prodi C; Deleonardi G; Gaspari V; Misciali C
Am J Dermatopathol; 2022 Mar; 44(3):198-200. PubMed ID: 34291744
[No Abstract] [Full Text] [Related]
38. Usefulness of skin testing in cutaneous drug eruptions in routine practice.
Tchen T; Reguiaï Z; Vitry F; Arnoult E; Grange A; Florent G; Bernard P
Contact Dermatitis; 2009 Sep; 61(3):138-44. PubMed ID: 19780771
[TBL] [Abstract][Full Text] [Related]
39. Contact urticaria during topical immunotherapy.
Tosti A; Guerra L; Bardazzi F
Contact Dermatitis; 1989 Sep; 21(3):196-7. PubMed ID: 2791547
[No Abstract] [Full Text] [Related]
40. Diphencyprone.
Lane PR; Hogan DJ
J Am Acad Dermatol; 1988 Aug; 19(2 Pt 1):364-5. PubMed ID: 3170804
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
